Page 33 - Jon Hamilton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jon Hamilton Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks. In 2014, Hamilton went to Liberia as part of the NPR team that covered Ebola. The team received a Peabody Award for its coverage. Following the 2011 earthquake and tsunami in Japan, Hamilton was part of NPR's team of science reporters and editors who went to Japan to cover the crisis at the Fukushima Dai-ichi nuclear power plant. Hamilton contributed several pieces to the Science Desk series "The Human Edge," which looked at what makes people the most versatile and power...

Many scientists have criticized the FDA for approving Aduhelm, a costly Alzheimer's drug that may not do much to slow the disease. But a patient taking the drug says it has given him hope.

In his resignation letter, Dr. Aaron Kesselheim calls it "probably the worst drug approval decision in recent U.S. history." An FDA official says the agency found the benefits outweighed the risks.

Three experts have now resigned from a Food and Drug Administration advisory committee after the agency approved an Alzheimer's drug called Aduhelm

In his resignation letter, Dr. Aaron Kesselheim calls it "probably the worst drug approval decision in recent U.S. history." An FDA official says the agency found the benefits outweighed the risks.